Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Thomas A. Fitzgerald currently holds 185,000 shares of Transcode Therapeutics, Inc. (RNAZ), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Thomas A. Fitzgerald has been a net buyer of RNAZ stock. They have purchased $40.4K and sold $0 worth of shares.
Thomas A. Fitzgerald's most recent insider trade was on Sep 9, 2026, when they sold 185,000 shares at $0.00 per share.
Thomas A. Fitzgerald serves as Executive at Transcode Therapeutics, Inc. (RNAZ). They have executed 4 insider transactions totaling $40.4K over their tenure at the company.
Thomas A. Fitzgerald holds the position of Executive at Transcode Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 4 years and currently hold a stake valued at $0.
Thomas A. Fitzgerald has shown a buying trading pattern, with $40.4K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Thomas A. Fitzgerald was on Sep 28, 2023, when they purchased $25.2K worth of RNAZ shares. This transaction involved 49,350 shares at $0.51 per share.
Thomas A. Fitzgerald currently owns 185,000 shares of Transcode Therapeutics, Inc. (RNAZ), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Thomas A. Fitzgerald's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Thomas A. Fitzgerald has 4 Form 4 filings on record as an insider at Transcode Therapeutics, Inc..
Set alerts for Thomas A. Fitzgerald and 40,000+ other insiders.